# Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer

> **NCT01529164** · PHASE2 · UNKNOWN · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 51 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Endostatins (Endostar)
- **DRUG:** Oxaliplatin
- **DRUG:** Leucovorin
- **DRUG:** 5-fluorouracil

## Key facts

- **NCT ID:** NCT01529164
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-10
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2013-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01529164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01529164, "Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01529164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*